Back

A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials

29 August 2017 (14:54 - 15:12)
Organised by:
Congress Presentation Part of: Stroke risk prediction in atrial fibrillation Atrial fibrillation (AF) ESC Premium Access ESC Congress 2017

About the speaker

Photo
Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)

4 More presentations in this session

Presentation thumbnail
State of the Art: stroke risk prediction in atrial fibrillation
Doctor I. Savelieva (London, GB)
Slides Video
Presentation thumbnail
Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc
Mr P. Nielsen (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry
Doctor M. Proietti (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Biomarkers for stroke risk prediction in atrial fibrillation
Professor J. Oldgren (Uppsala, SE)
Slides Video

Access the full session

Session thumbnail
Stroke risk prediction in atrial fibrillation

The Event

Event poster

ESC Congress 2017

29 August 2017 14:54 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources